Ayala Pharmaceuticals Inc (AYLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,055 | 16,725 | N/A | N/A | N/A |
| Marketable Securities | 81 | 83 | N/A | N/A | N/A |
| Receivables | 1,001 | 469 | N/A | N/A | N/A |
| TOTAL | $11,450 | $17,694 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1,388 | 1,421 | N/A | N/A | N/A |
| Other Non-Current Assets | 2,324 | 939 | 0 | 0 | 0 |
| TOTAL | $3,712 | $2,360 | $N/A | $N/A | $N/A |
| Total Assets | $15,162 | $20,054 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,466 | 5,302 | 0 | 0 | 0 |
| TOTAL | $6,466 | $5,302 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 548 | 299 | 0 | 0 | 0 |
| TOTAL | $548 | $299 | $N/A | $N/A | $N/A |
| Total Liabilities | $7,014 | $5,601 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,779 | N/A | N/A | N/A | N/A |
| Common Shares | 51 | 51 | N/A | N/A | N/A |
| Retained earnings | -47,339 | -40,741 | N/A | N/A | N/A |
| TOTAL | $8,148 | $14,453 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $15,162 | $20,054 | $0 | $0 | $0 |